<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38200486</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study.</ArticleTitle><Pagination><StartPage>12</StartPage><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-023-03237-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">The health care is likely to break down unless we are able to increase the level of functioning for the growing number of patients with complex, chronic illnesses. Hence, novel high-capacity and cost-effective treatments with trans-diagnostic effects are warranted. In accordance with the protocol paper, we aimed to examine the acceptability, satisfaction, and effectiveness of an interdisciplinary micro-choice based concentrated group rehabilitation for patients with chronic low back pain, long COVID, and type 2 diabetes.</AbstractText><AbstractText Label="METHODS">Patients with low back pain &gt; 4 months sick-leave, long COVID, or type 2 diabetes were included in this clinical trial with pre-post design and 3-month follow-up. The treatment consisted of three phases: (1) preparing for change, (2) the concentrated intervention for 3-4 days, and (3) integrating change into everyday life. Patients were taught and practiced how to monitor and target seemingly insignificant everyday micro-choices, in order to break the patterns where symptoms or habits contributed to decreased levels of functioning or increased health problems. The treatment was delivered to groups (max 10 people) with similar illnesses. Client Satisfaction Questionnaire (CSQ-8)) (1 week), Work and Social Adjustment Scale (WSAS), Brief Illness Perception Questionnaire (BIPQ), and self-rated health status (EQ-5D-5L) were registered at baseline and 3-month follow-up.</AbstractText><AbstractText Label="RESULTS">Of the 241 included participants (57% women, mean age 48 years, range 19-84), 99% completed the concentrated treatment. Treatment satisfaction was high with a 28.9 (3.2) mean CSQ-8-score. WSAS improved significantly from baseline to follow-up across diagnoses 20.59 (0.56) to 15.76 (0.56). BIPQ improved from: 22.30 (0.43) to 14.88 (0.47) and EQ-5D-5L: 0.715 (0.01) to 0.779 (0.01)), all P&lt;0.001.</AbstractText><AbstractText Label="CONCLUSIONS">Across disorders, the novel approach was associated with high acceptability and clinically important improvements in functional levels, illness perception, and health status. As the concentrated micro-choice based treatment format might have the potential to change the way we deliver rehabilitation across diagnoses, we suggest to proceed with a controlled trial.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov NCT05234281.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kvale</LastName><ForeName>Gerd</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Psychology, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>S&#xf8;fteland</LastName><ForeName>Eirik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7221-1013</Identifier><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway. eirik.softeland@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway. eirik.softeland@uib.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway. eirik.softeland@uib.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xfc;rgensen</LastName><ForeName>Marte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilhelmsen-Langeland</LastName><ForeName>Ane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Psychiatry, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haugstvedt</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hystad</LastName><ForeName>Sigurd William</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Psychosocial Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd8;degaard-Olsen</LastName><ForeName>&#xd8;ystein Theodor</ForeName><Initials>&#xd8;T</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarli</LastName><ForeName>Bernt B&#xf8;gvald</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rykken</LastName><ForeName>Sidsel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frisk</LastName><ForeName>Bente</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Helse i Hardanger, Kvam, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health and Functioning, Western Norway University of Applied Sciences, Bergen, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05234281</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>389457</GrantID><Agency>EkstraStiftelsen Helse og Rehabilitering (Stiftelsen Dam)</Agency><Country/></Grant><Grant><GrantID>389461</GrantID><Agency>EkstraStiftelsen Helse og Rehabilitering (Stiftelsen Dam)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017116" MajorTopicYN="Y">Low Back Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anxiety</Keyword><Keyword MajorTopicYN="N">Chronic illness</Keyword><Keyword MajorTopicYN="N">Concentrated rehabilitation</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Low back pain</Keyword><Keyword MajorTopicYN="N">Micro-choice</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">Type 2 Diabetes</Keyword></KeywordList><CoiStatement>Two authors, &#xd8;T&#xd8;O and SR, are shareholders of Helse i Hardanger, a not-for-profit health clinic. No other competing interests are reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38200486</ArticleId><ArticleId IdType="pmc">PMC10782659</ArticleId><ArticleId IdType="doi">10.1186/s12916-023-03237-3</ArticleId><ArticleId IdType="pii">10.1186/s12916-023-03237-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Noncommunicable diseases. https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_1.</Citation></Reference><Reference><Citation>Akseer N, Mehta S, Wigle J, Chera R, Brickman ZJ, Al-Gashm S, et al. Non-communicable diseases among adolescents: current status, determinants, interventions and policies. BMC Public Health. 2020;20:1&#x2013;20. doi: 10.1186/s12889-020-09988-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09988-5</ArticleId><ArticleId IdType="pmc">PMC7734741</ArticleId><ArticleId IdType="pubmed">33317507</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira CB, Maher CG, Pinto RZ, Traeger AC, Lin CWC, Chenot JF, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27:2791&#x2013;803. doi: 10.1007/s00586-018-5673-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00586-018-5673-2</ArticleId><ArticleId IdType="pubmed">29971708</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Rehabilitation and COVID-19. https://www.who.int/teams/noncommunicable-diseases/covid-19/rehabilitation.</Citation></Reference><Reference><Citation>Care D, Suppl SS. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes&#x2014;2022. Diabetes Care. 2022;45 January:S60&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">34964866</ArticleId></ArticleIdList></Reference><Reference><Citation>Carver CS, Scheier MF. Situational coping and coping dispositions in a stressful transaction. J Pers Soc Psychol. 1994;66:184&#x2013;95. doi: 10.1037/0022-3514.66.1.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-3514.66.1.184</ArticleId><ArticleId IdType="pubmed">8126648</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bergh O, Witth&#xf6;ft M, Petersen S, Brown RJ. Symptoms and the body: taking the inferential leap. Neurosci Biobehav Rev. 2017;74:185&#x2013;203. doi: 10.1016/j.neubiorev.2017.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.01.015</ArticleId><ArticleId IdType="pubmed">28108416</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvale G, Frisk B, J&#xfc;rgensen M, B&#xf8;rtveit T, &#xd8;degaard-Olsen &#xd8;T, Wilhelmsen-Langeland A, et al. Evaluation of novel concentrated interdisciplinary group rehabilitation for patients with chronic illnesses: Protocol for a nonrandomized clinical intervention study. JMIR Res Protoc. 2021;10(10):e32216. doi: 10.2196/32216.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/32216</ArticleId><ArticleId IdType="pmc">PMC8500350</ArticleId><ArticleId IdType="pubmed">34505838</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisk B, Nj&#xf8;ten KL, Aarli B, Hystad SW, Rykken S, Kjos&#xe5;s A, et al. A Novel concentrated, interdisciplinary group rehabilitation program for patients with chronic obstructive pulmonary disease: protocol for a nonrandomized clinical intervention study. JMIR Res Protoc. 2022;11:e40700. doi: 10.2196/40700.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/40700</ArticleId><ArticleId IdType="pmc">PMC9647463</ArticleId><ArticleId IdType="pubmed">36287602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvale G, Langeland AW, J&#xfc;rgensen M, Hystad SW, &#xd6;st LG. Concentrated transdiagnostic and cross &#x2011; disciplinary group treatment for patients with depression and with anxiety&#x202f;: a pilot study. BMC Psychiatry. 2022;:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441319</ArticleId><ArticleId IdType="pubmed">36058925</ArticleId></ArticleIdList></Reference><Reference><Citation>NAV. Sick leave and disability statistics. 2023. https://www.nav.no/no/nav-og-samfunn/statistikk/sykefravar-statistikk/sykefravar.</Citation></Reference><Reference><Citation>Hansen B, Hagen K, &#xd6;st L-G, Solem S, Kvale G. The Bergen 4-day OCD treatment delivered in a group setting: 12-month follow-up. Front Psychol. 2018;9:639. doi: 10.3389/fpsyg.2018.00639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2018.00639</ArticleId><ArticleId IdType="pmc">PMC5943612</ArticleId><ArticleId IdType="pubmed">29774005</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubhaug B, Lier HO, A&#xdf;mus J, Rongve A, Kvale G. A 4-Day Mindfulness-Based Cognitive Behavioral Intervention Program for CFS/ME. An Open Study, With 1-Year Follow-Up. Front Psychiatry. 2018;9:720. doi: 10.3389/fpsyt.2018.00720.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2018.00720</ArticleId><ArticleId IdType="pmc">PMC6306445</ArticleId><ArticleId IdType="pubmed">30618889</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen B, Kvale G, Hagen K, Havnen A, &#xd6;st L-G. The Bergen 4-day treatment for OCD: four years follow-up of concentrated ERP in a clinical mental health setting. Cogn Behav Ther. 2019;48:89&#x2013;105. doi: 10.1080/16506073.2018.1478447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/16506073.2018.1478447</ArticleId><ArticleId IdType="pubmed">30088441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvale G, Hansen B, Bj&#xf6;rgvinsson T, B&#xf8;rtveit T, Hagen K, Haseth S, et al. Successfully treating 90 patients with obsessive compulsive disorder in eight days: the Bergen 4-day treatment. BMC Psychiatry. 2018;18:323. doi: 10.1186/s12888-018-1887-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-018-1887-4</ArticleId><ArticleId IdType="pmc">PMC6172736</ArticleId><ArticleId IdType="pubmed">30286745</ArticleId></ArticleIdList></Reference><Reference><Citation>Launes G, Hagen K, Sunde T, &#xd6;st L-G, Klovning I, Laukvik I-L, et al. A Randomized Controlled Trial of Concentrated ERP, Self-Help and Waiting List for Obsessive- Compulsive Disorder: The Bergen 4-Day Treatment. Front Psychol. 2019;10:2500. doi: 10.3389/fpsyg.2019.02500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2019.02500</ArticleId><ArticleId IdType="pmc">PMC6873786</ArticleId><ArticleId IdType="pubmed">31803089</ArticleId></ArticleIdList></Reference><Reference><Citation>Helse i Hardanger (introduction film).2021. https://www.youtube.com/watch?v=qHW0IIlW_QM&amp;t=124s</Citation></Reference><Reference><Citation>Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann. 1983;6(3&#x2013;4):299&#x2013;313. doi: 10.1016/0149-7189(83)90010-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0149-7189(83)90010-1</ArticleId><ArticleId IdType="pubmed">10267258</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60:631&#x2013;7. doi: 10.1016/j.jpsychores.2005.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2005.10.020</ArticleId><ArticleId IdType="pubmed">16731240</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ. A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol Heal. 2015;30:1361&#x2013;85. doi: 10.1080/08870446.2015.1070851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08870446.2015.1070851</ArticleId><ArticleId IdType="pubmed">26181764</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt JC, Marks IM, Shear MK, Greist JH. The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461&#x2013;4. doi: 10.1192/bjp.180.5.461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.180.5.461</ArticleId><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011;20:1727&#x2013;36. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin N, Roudijk B, Ludwig K, editors. Value Sets for EQ-5D-5L. Cham: Springer International Publishing; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">36810025</ArticleId></ArticleIdList></Reference><Reference><Citation>Garratt AM, Hansen TM, Augestad LA, Rand K, Stavem K. Norwegian population norms for the EQ-5D-5L: results from a general population survey. Qual Life Res. 2022;31:517&#x2013;26. doi: 10.1007/s11136-021-02938-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02938-7</ArticleId><ArticleId IdType="pmc">PMC8284681</ArticleId><ArticleId IdType="pubmed">34272631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863. doi: 10.3389/fpsyg.2013.00863.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2013.00863</ArticleId><ArticleId IdType="pmc">PMC3840331</ArticleId><ArticleId IdType="pubmed">24324449</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisk B, J&#xfc;rgensen M, Espehaug B, Nj&#xf8;ten KL, S&#xf8;fteland E, Aarli BB, et al. OPEN A safe and effective micro &#x2011; choice based rehabilitation for patients with long COVID&#x202f;: results from a quasi &#x2011; experimental study. Sci Rep. 2023;:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10252160</ArticleId><ArticleId IdType="pubmed">37296140</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Garratt AM, Furunes H, Hellum C, Solberg T, Brox JI, Storheim K, et al. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients. Health Qual Life Outcomes. 2021;19:1&#x2013;9. doi: 10.1186/s12955-021-01792-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01792-y</ArticleId><ArticleId IdType="pmc">PMC8160396</ArticleId><ArticleId IdType="pubmed">34049574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryum T, Stiles TC. Changes in pain catastrophizing, fear-avoidance beliefs, and pain self-efficacy mediate changes in pain intensity on disability in the treatment of chronic low back pain. PAIN Reports. 2023;8:e1092. doi: 10.1097/PR9.0000000000001092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000001092</ArticleId><ArticleId IdType="pmc">PMC10501475</ArticleId><ArticleId IdType="pubmed">37719924</ArticleId></ArticleIdList></Reference><Reference><Citation>Godfrey E, Wileman V, Galea Holmes M, McCracken LM, Norton S, Moss-Morris R, et al. Physical therapy informed by acceptance and commitment therapy (PACT) versus usual care physical therapy for adults with chronic low back pain: a randomized controlled trial. J Pain. 2020;21:71&#x2013;81. doi: 10.1016/j.jpain.2019.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2019.05.012</ArticleId><ArticleId IdType="pubmed">31173921</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen B, Kvale G, Hagen K, Hjelle KM, Solem S, B&#xf8; B, et al. The Bergen 4-day treatment for panic disorder: a pilot study. Front Psychol. 2018;9:1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029556</ArticleId><ArticleId IdType="pubmed">29997546</ArticleId></ArticleIdList></Reference><Reference><Citation>Vibe Fersum K, O&#x2019;Sullivan P, Skouen JS, Smith A, Kv&#xe5;le A. Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: a randomized controlled trial. Eur J Pain. 2013;17:916&#x2013;28. doi: 10.1002/j.1532-2149.2012.00252.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.1532-2149.2012.00252.x</ArticleId><ArticleId IdType="pmc">PMC3796866</ArticleId><ArticleId IdType="pubmed">23208945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391:2356&#x2013;67. doi: 10.1016/S0140-6736(18)30480-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30480-X</ArticleId><ArticleId IdType="pubmed">29573870</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KGI, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607&#x2013;13. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshirgaran SM, Stephens C, Alpass F, Aminisani N. Longitudinal assessment of the health-related quality of life among older people with diabetes: results of a nationwide study in New Zealand. BMC Endocr Disord. 2020;20:1&#x2013;9. doi: 10.1186/s12902-020-0519-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-020-0519-4</ArticleId><ArticleId IdType="pmc">PMC7059720</ArticleId><ArticleId IdType="pubmed">32138698</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>